Back
Royal Caribbean Group Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
69
RCL
Royal Caribbean Group
Last Price:
140.60
Seasonality Move:
3.33%
Sell
45
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
34.39
Seasonality Move:
-9.19%
Buy
69
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $140.59. The Score for RCL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $34.25. The Score for CRBP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $140.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $34.25
The current trend is moderately bearish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.4 | Buy |
Relative Strength Index (14 RSI): | 64.91 | Buy |
Chaikin Money Flow: | 2364054 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (130 - 138.9) | Buy |
Bollinger Bands (100): | (119.56 - 132.88) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 43.27 | Sell |
Chaikin Money Flow: | 61510 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.63 - 40.09) | Sell |
Bollinger Bands (100): | (9.33 - 38.21) | Buy |
RCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 133.53 | Buy |
20-day SMA: | 133.67 | Buy |
50-day SMA: | 129.77 | Buy |
200-day SMA: | 111.54 | Buy |
8-day EMA: | 135.26 | Buy |
20-day EMA: | 133.47 | Buy |
50-day EMA: | 130.3 | Buy |
200-day EMA: | 112.73 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.43 | Sell |
20-day SMA: | 38.25 | Sell |
50-day SMA: | 36.25 | Sell |
200-day SMA: | 14.94 | Buy |
8-day EMA: | 36.28 | Sell |
20-day EMA: | 37.41 | Sell |
50-day EMA: | 34.26 | Sell |
200-day EMA: | 19.79 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.30 per share, a decrease next quarter of $1.54 per share, an increase this year of $4.13 per share, and an increase next year of $1.54 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
Royal Caribbean Group Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |